John Armitage - Egerton Capital (UK) LLP
Holding/activity history for Boston Scientific (BSX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 0 | 0.00 | Sell 100.00% | 5.58 | SEC | ||
| 2025 Q4 | 5,385,084 | 5.58 | Add 1.37% | 0.08 | $95.35 | $513,467,759 | SEC |
| 2025 Q3 | 5,312,504 | 5.47 | Add 223.74% | 3.78 | $97.63 | $518,659,766 | SEC |
| 2025 Q2 | 1,640,956 | 1.81 | Buy | 1.81 | $107.41 | $176,255,084 | SEC |